The North Chicago medical device maker today announced the U.S. Food & Drug Administration has authorized the use of its new coronavirus test, which delivers positive results within five minutes and negative results within 13.

The test, which runs on an existing, portable Abbott platform, can be used in various health care settings, including urgent care clinics and emergency departments, according to a statement. The company says it will eventually be able to make 50,000 tests available per day.

"The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus," Abbott Chief Operating Officer Robert Ford, who will soon step into the CEO role, said in the statement.

Abbott says it plans to make tests available to clinicians in urgent care settings around the country next week.

Last week, the company announced it was ramping up production of another newly approved COVID-19 test, which leverages an existing molecular diagnostic system that can run up to 470 tests in 24 hours. Abbott expects to be producing about 5 million total tests per month in April.